10-Q: Trupanion Reports Strong Revenue Growth in Q2 2026
Quarterly Report
Trupanion, Inc. announced its second quarter 2026 financial results, showcasing an 11% increase in total revenue driven by its subscription business, alongside strategic investments in growth and operational efficiencies.
Summary
- Trupanion reported an 11% increase in total revenue for the three months ended June 30, 2026, reaching $392.9 million, compared to $353.6 million in the prior year period.
- The subscription business segment saw a 14% revenue increase to $276.7 million, driven by a 9% rise in monthly average revenue per pet and a 5% increase in enrolled pets.
- Net income for the quarter was $6.8 million, or $0.16 per diluted share, a decrease from $9.4 million ($0.22 per diluted share) in the prior year, impacted by increased operating expenses.
- For the six months ended June 30, 2026, total revenue grew 12% to $777.0 million, with net income at $11.7 million ($0.27 per diluted share), up from $7.9 million ($0.19 per diluted share) in the prior year period.
- Technology and development expenses increased significantly by 49% year-over-year for the quarter, largely due to stock-based compensation and new product exploration.
- The company ended the quarter with $149.4 million in cash and cash equivalents, and $249.1 million in short-term investments.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this filing as moderately positive, reflecting solid revenue growth and improved profitability, though offset by increased acquisition costs and some unfavorable claims development.
Positives
- Total revenue increased by 11% to $392.9 million for the three months ended June 30, 2026.
- Subscription business revenue grew by 14% to $276.7 million, indicating strong core business performance.
- Monthly average revenue per pet in the subscription business increased by 9% to $87.44 for the quarter.
- Total subscription pets enrolled increased by 5% to 1,124,548.
- The company's other business segment revenue saw a 4% increase to $116.2 million.
- Net income for the six-month period increased to $11.7 million from $7.9 million in the prior year.
- Average monthly retention remained strong at 98.37%.
Negatives
- Net income for the three months ended June 30, 2026, decreased to $6.8 million from $9.4 million in the prior year.
- Technology and development expenses increased by 49% year-over-year for the quarter, impacting profitability.
- New pet acquisition expenses increased by 15% for the quarter, indicating higher costs to acquire new customers.
- Unfavorable development on veterinary invoice reserves was noted in both subscription ($2.9 million for prior years) and other business segments ($3.2 million total for the six months).
- The company expects a decline in revenue from the Pets Best relationship, which accounted for 30% of total revenue in 2025.
Risks
- The contractual relationship with Pets Best is ending after Q3 2028, which is expected to significantly reduce revenue and associated expenses in the other business segment.
- The roll-off of the Pets Best business may divert management attention from the core subscription business.
- Reduced revenue from the Pets Best relationship will increase dependence on the subscription business segment.
- The share repurchase program may not enhance long-term stockholder value and will diminish cash reserves.
- Unfavorable development on veterinary invoice reserves, driven by higher than expected claim frequency in prior accident years, could impact future profitability.
- Increased marketing spend for new pet acquisition, while disciplined, has led to higher acquisition costs.
Future Outlook
The company believes its operating cash flow is sufficient to fund operations and capital requirements for the next 12 months. However, it may explore additional financing for growth or strategic purposes. The company anticipates continued decline in enrollment from Pets Best as the relationship concludes after Q3 2028.
Management Comments
- We operate in two reporting segments: subscription business and other business.
- Our growing and loyal membership base provides us with highly predictable and recurring revenue.
- We monitor average pet acquisition cost to evaluate the efficiency in acquiring new members and measure effectiveness based on our targeted return on investment.
- The Company does not intend to declare or pay any cash dividends in the foreseeable future.
- We have begun deploying more capital to acquire new pets in a disciplined manner.
Industry Context
StockSavvy.ai notes that Trupanion's performance aligns with broader trends in the pet insurance market, which continues to see growth driven by increasing pet ownership and a greater willingness among owners to invest in pet healthcare. However, rising veterinary costs and claim frequencies present ongoing challenges for insurers in maintaining profitability.
Comparison to Industry Standards
- Trupanion's subscription business revenue growth of 14% for the quarter outpaces general industry growth rates for pet insurance.
- The company's average monthly retention rate of 98.37% is considered very high within the insurance industry, indicating strong customer loyalty.
- The increase in average pet acquisition cost (PAC) to $299 for the quarter is a concern, as higher PAC can pressure profitability if not offset by increased customer lifetime value or revenue per pet.
- The veterinary invoice expense as a percentage of subscription revenue (71% for the six months) is a key metric to monitor, as it directly impacts the core profitability of the business. Industry benchmarks for this ratio can vary, but maintaining it below 75% is generally considered healthy.
Legal Proceedings
- The company is subject to various legal proceedings arising in the ordinary course of business, but does not believe any are material individually or in the aggregate.
Stakeholder Impact
- Shareholders: The company has approved a new $100 million share repurchase program, which could impact stock price and volatility. The decrease in quarterly net income may be a concern, while the increase in six-month net income is positive.
- Employees: Stock-based compensation remains a significant expense, impacting net income but also serving as an incentive.
- Customers (Pet Owners): Continued focus on member experience and retention is crucial. The company's ability to manage veterinary invoice expenses and pricing will impact the value proposition.
- Business Partners (Veterinarians): The company continues to invest in relationships with veterinary hospitals through its Territory Partners program.
Next Steps
- Continue to focus on achieving target margins in the subscription business.
- Acquire new pets at targeted average estimated internal rates of return.
- Manage the roll-off of the Pets Best business and its impact on the other business segment.
- Continue to invest in technology and development for new products and member experience enhancements.
- Monitor and manage veterinary invoice expenses and adjust pricing as needed.
Key Dates
| Date | Description |
|---|---|
| 2025-02-13 | Filing of Annual Report on Form 10-K for the fiscal year ended December 31, 2025. |
| 2025-06-30 | End of the second fiscal quarter for the reported period. |
| 2025-11-04 | Company entered into the PNC Facility credit agreement. |
| 2026-01-01 | Beginning of the six-month period ended June 30, 2026. |
| 2026-02-XX | APIC distributed extraordinary dividends of $14.9 million. |
| 2026-03-31 | End of the first fiscal quarter for the reported period. |
| 2026-05-11 | Margi Tooth adopted a Rule 10b5-1 trading plan. |
| 2026-06-XX | Board approved a new share repurchase program. |
| 2026-06-30 | End of the second fiscal quarter and reporting period. |
| 2026-07-29 | Date as of which shares outstanding were reported. |
| 2026-07-31 | End date for Margi Tooth's Rule 10b5-1 trading plan. |
| 2026-08-05 | Date of the report's signatures. |
| 2026-08-XX | APIC distributed extraordinary dividends of $10.0 million. |
| 2028-07-XX | Agreed end date for the relationship with Pets Best. |
| 2028-11-04 | Maturity date for the PNC Facility. |
Recommendation
holdThe company demonstrates consistent revenue growth in its core subscription business and strong retention rates. However, the significant increase in technology and development expenses, higher pet acquisition costs, and the impending wind-down of the substantial Pets Best business introduce near-term uncertainties and pressure on profitability. While the six-month net income shows improvement, the quarterly decline warrants a cautious approach. Therefore, a 'hold' recommendation is appropriate pending clearer visibility on the impact of these factors and the successful transition away from the Pets Best revenue stream.
Keywords
pet insurance, subscription revenue, veterinary invoice expense, pet acquisition cost, financial results, operating income, comprehensive income, cash flow
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.